EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features

Zhen-Zhong Zhou, Jia-Chen Lu, Song-Bin Guo, Xiao-Peng Tian iD, Hai-Long Li, Hui Zhou, Wei-Juan Huang

Cancer Medicine · 2025

DOI: 10.1002/cam4.70602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Zhen-Zhong Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Mitochondria, Biomarkers, Tumor. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities, Sun Yat-sen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Distinctive heterogeneity characterizes diffuse large B‐cell lymphoma (DLBCL), one of the most frequent types of non‐Hodgkin's lymphoma. Mitochondria have been demonstrated to be closely involved in tumorigenesis and progression, particularly in DLBCL.

Objective

The purposes of this study were to identify the prognostic mitochondria‐related genes (MRGs) in DLBCL, and to develop a risk model based on MRGs and machine learning algorithms.

Methods

Transcriptome profiles and clinical information were obtained from the Gene Expression Omnibus (GEO) database. The risk model was defined using Least Absolute Shrinkage and Selection Operator (Lasso) regression algorithm, and its prognostic value was further examined in independent datasets. Patients were stratified into two clusters based on the risk scores, additionally a nomogram was generated based on the risk score and clinical characteristics. Gene pathway level, microenvironment, expression of targeted therapy‐associated genes, response to immunotherapy, drug sensitivity, and somatic mutation status were compared between clusters.

Results

Eighteen prognostic MRGs (DNM1L, PUSL1, CHCHD4, COX7A1, CPT1A, CYP27A1, POLDIP2, PCK2, MRPL2, PDK3, PDK4, MARC2, ACSM3, COA7, THNSL1, ATAD3B, C15orf48, TOMM70A) were identified to construct the risk model. Remarkable discrepancies were observed between groups. The high‐risk group had shorter overall survival, less immune infiltration, lower CD20 and higher PD‐L1 expression than the low‐risk group. Distinct immune microenvironment, responses to immunotherapy and predictive drug IC50 values were found between groups.

Conclusions

We established a novel prognostic mitochondria‐related signature by machine learning algorithm, which also demonstrated outstanding predictive value in tumor microenvironment and responses to therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseMitochondriaBiomarkers, TumorHumansPrognosisNomogramsTumor MicroenvironmentTranscriptomeGene Expression Regulation, NeoplasticMaleFemaleGene Expression ProfilingMachine LearningMiddle Aged

Stichwörter der Autor:innen

diffuse large B‐cell lymphomadrug sensitivitygene set enrichment analysisimmune environmentmitochondria‐related genesprognostic model

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Department of Respiratory Oncology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.

ORCID-Profile: Xiao-Peng Tian

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundamental Research Funds for the Central Universities, Sun Yat-sen University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhou, Z. Z., Lu, J. C., Guo, S. B., Tian, X. P., Li, H. L., Zhou, H., & Huang, W. J. (2025). A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features. Cancer Medicine. https://doi.org/10.1002/cam4.70602

Vancouver

Zhou ZZ, Lu JC, Guo SB, Tian XP, Li HL, Zhou H, et al. A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features. Cancer Medicine. 2025. doi:10.1002/cam4.70602

BibTeX
@article{Zhou2025,
  author = {Zhou, Zhen-Zhong and Lu, Jia-Chen and Guo, Song-Bin and Tian, Xiao-Peng and Li, Hai-Long and Zhou, Hui and Huang, Wei-Juan},
  title = {A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70602}
}
Kostenlos starten →